Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xinghua GL Stevia is a specialized manufacturer focused on the research, development, and large-scale production of high-purity stevia extracts. The company provides a comprehensive portfolio of natural, zero-calorie sweeteners, including Rebaudioside A, Rebaudioside D, and Rebaudioside M, catering to the global food, beverage, and nutraceutical industries. GL Stevia maintains a vertically integrated supply chain, managing everything from stevia leaf cultivation and seedling selection to advanced extraction and purification processes. Their products are designed to support sugar reduction initiatives and provide healthy alternatives for managing metabolic conditions like diabetes and obesity. The company operates under international quality standards, holding certifications such as GMP, ISO, and various organic designations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xinghua GL Stevia.